Xenon Pharmaceuticals Inc. (NASDAQ:XENE) Q3 2022 Earnings Call Transcript November 8, 2022
Xenon Pharmaceuticals Inc. misses on earnings expectations. Reported EPS is $-0.57 EPS, expectations were $-0.52.
Operator: Good day, and thank you for standing by. Welcome to the Q3 2022 Xenon Pharmaceuticals, Inc. Earnings Conference Call. After the speakers presentation there will be a question and answer session. Please be advised that today’s conference is being recorded. I would now like to hand...
